According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are $1.89 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $1.89 B | 6.67% |
2022-12-31 | $1.77 B | 1.89% |
2021-12-31 | $1.73 B | -0.17% |
2020-12-31 | $1.74 B | 11.12% |
2019-12-31 | $1.56 B | 7.43% |
2018-12-31 | $1.45 B | -20.02% |
2017-12-31 | $1.82 B | 45.1% |
2016-12-31 | $1.25 B | -5.35% |
2015-12-31 | $1.32 B | 40.22% |
2014-12-31 | $0.94 B | 4.92% |
2013-12-31 | $0.90 B | 63.42% |
2012-12-31 | $0.55 B | 3.74% |
2011-12-31 | $0.53 B | -2.33% |
2010-12-31 | $0.54 B | -8.34% |
2009-12-31 | $0.59 B | -5.56% |
2008-12-31 | $0.63 B | 0.39% |
2007-12-31 | $0.62 B | 81.57% |
2006-12-31 | $0.34 B | 26.71% |
2005-12-31 | $0.27 B | -9.36% |
2004-12-31 | $0.30 B | 117.31% |
2003-12-31 | $0.13 B | 1047.08% |
2002-12-31 | $12.07 M | -1.55% |
2001-12-31 | $12.26 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Sanofi SNY | $57.61 B | 2,948.23% | ๐ซ๐ท France |
Ultragenyx RARE | $1.21 B | -35.68% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | $82.43 M | -95.64% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | $0.66 B | -65.04% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $0.61 B | -67.32% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | $82.23 M | -95.65% | ๐บ๐ธ USA |